BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21586205)

  • 21. [Update: polyarteritis nodosa].
    Schirmer JH; Moosig F
    Z Rheumatol; 2018 Jun; 77(5):397-408. PubMed ID: 29808333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
    Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
    Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute cholecystitis at initial presentation of polyarteritis nodosa.
    Fernandes SR; Samara AM; Magalhães EP; Sachetto Z; Metze K
    Clin Rheumatol; 2005 Nov; 24(6):625-7. PubMed ID: 15789142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab.
    Matsuo S; Hayashi K; Morimoto E; Kato A; Sada KE; Watanabe H; Takano-Narazaki M; Sunahori-Watanabe K; Kawabata T; Wada J
    Intern Med; 2017; 56(11):1435-1438. PubMed ID: 28566612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cutaneous periarteritis nodosa: diagnostic and therapeutic aspects of 9 cases].
    Maillard H; Szczesniak S; Martin L; Garot D; Machet MC; Machet L; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):125-9. PubMed ID: 10352826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.
    Guillevin L; Fain O; Lhote F; Jarrousse B; Le Thi Huong D; Bussel A; Leon A
    Arthritis Rheum; 1992 Feb; 35(2):208-15. PubMed ID: 1346499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of pediatric vasculitis with a focus on juvenile polyarteritis nodosa.
    Kawakami T
    Am J Clin Dermatol; 2012 Dec; 13(6):389-98. PubMed ID: 22845169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of systemic necrotizing vasculitides: recent advances and important clinical considerations.
    Pagnoux C; Mendel A
    Expert Rev Clin Immunol; 2019 Sep; 15(9):939-949. PubMed ID: 31414912
    [No Abstract]   [Full Text] [Related]  

  • 29. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment.
    Lhote F; Guillevin L
    Rheum Dis Clin North Am; 1995 Nov; 21(4):911-47. PubMed ID: 8592743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.
    Samson M; Puéchal X; Mouthon L; Devilliers H; Cohen P; Bienvenu B; Ly KH; Bruet A; Gilson B; Ruivard M; Pertuiset E; Hamidou M; Pagnoux C; Terrier B; Guillevin L;
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):176-184. PubMed ID: 28422001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of anti-phosphatidylserine-prothrombin complex antibodies and anti-moesin antibodies in patients with polyarteritis nodosa.
    Okano T; Takeuchi S; Soma Y; Suzuki K; Tsukita S; Ishizu A; Suzuki K; Kawakami T
    J Dermatol; 2017 Jan; 44(1):18-22. PubMed ID: 27345569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment.
    Guillevin L; Lhote F
    Curr Opin Rheumatol; 1995 Jan; 7(1):20-4. PubMed ID: 7718418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microscopic polyangiitis: clinical aspects and treatment.
    Lhote F; Cohen P; Généreau T; Gayraud M; Guillevin L
    Ann Med Interne (Paris); 1996; 147(3):165-77. PubMed ID: 8796093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of systemic vasculitides].
    Guillevin L; Pagnoux C
    Rev Prat; 2008 Mar; 58(5):541-4. PubMed ID: 18524111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B-related polyarteritis nodosa presenting necrotizing vasculitis in the hepatobiliary system successfully treated with lamivudine, plasmapheresis and glucocorticoid.
    Takeshita S; Nakamura H; Kawakami A; Fukushima T; Gotoh T; Ichikawa T; Tsujino A; Ida H; Toriyama K; Hayashi T; Eguchi K
    Intern Med; 2006; 45(3):145-9. PubMed ID: 16508228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of polyarteritis nodosa and Churg-Strauss angiitis: indications of plasma exchange. Results of three prospective trials in 162 patients. The Cooperative Study Group for the Study of Polyarteritis Nodosa.
    Guillevin L
    Prog Clin Biol Res; 1990; 337():309-17. PubMed ID: 1972283
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastrointestinal tract involvement in polyarteritis nodosa and Churg-Strauss syndrome.
    Guillevin L; Lhote F; Gallais V; Jarrousse B; Royer I; Gayraud M; Benichou J
    Ann Med Interne (Paris); 1995; 146(4):260-7. PubMed ID: 7653948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
    Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
    J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous polyarteritis nodosa in pediatric patients successfully treated with TNF-α inhibitor and methotrexate: Case series and literature review.
    Do N; Ringold S; Brandling-Bennett H
    Pediatr Dermatol; 2019 Nov; 36(6):932-935. PubMed ID: 31576593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nodular and granulomatous form of periarteritis nodosa caused by the hepatitis B virus].
    Turki S; Guillevin L; Dallot A; Jarrousse B; Vernier I; Laroche L; Pourrat J; Amouroux J
    Ann Dermatol Venereol; 1994; 121(4):325-7. PubMed ID: 7702253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.